End-of-year victory for lawmakers as health care policies pass in the House; insurance limitations prompt concerns over access to semaglutide (Ozempic) for diabetes; a legal battle ensues over the fate of abortion laws in Arizona.
The House passed a significant health care package in a bipartisan 320-71 vote, marking an end-of-year accomplishment after previous setbacks, according to Stat. While the bill is unlikely to pass the Senate in its current form, the policies, including equalizing drug administration payments in Medicare across hospital outpatient departments and physician offices, addressing pharmacy benefit manager practices, and implementing health care price transparency rules, gain visibility for potential inclusion in a government funding deal. The most debated aspect, the Lower Costs, More Transparency Act, featuring site-neutral payments for drug administration, faces opposition from hospitals concerned about potential financial consequences and broader Medicare implications.
Some patients with type 2 diabetes are experiencing challenges in getting reimbursed for drugs like semaglutide (Ozempic) due to US insurers implementing restrictions to discourage prescribing the medication for weight loss, according to Reuters. Novo Nordisk acknowledged tighter health plan management of glucagon-like peptide-1 drugs, contributing to a recent decline in US prescriptions. Patients report delays and obstacles, including prior authorization requirements and the need to try alternative medications, raising concerns about potential impacts on diabetes management and overall health outcomes.
The Arizona State Supreme Court is set to hear oral arguments regarding the potential reinstatement of a centuries-old near-total abortion ban, with conflicting laws causing uncertainty after the US Supreme Court overturned Roe v Wade, according to ABC News. The current 15-week abortion ban in Arizona faces challenges, and the court will decide whether the 1864 law, which bans abortion with criminal penalties, will be enforced. Planned Parenthood Arizona aims to affirm the Court of Appeals' decision to preserve abortion access, while abortion advocates simultaneously seek a ballot measure to secure abortion rights in the state's constitution.
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More